Last updated: 2026-10-14 11:36:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
CapsoVision, Inc. (CV) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $6.77, with a market capitalisation of $359.70M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.46 to $15.37. This page covers its latest market performance, valuation, price trends and company information.
$359.70M | |
$6.77 | |
$41.05 | |
$3.43 | |
$6.78 | |
10.00 | |
157.65K | |
-- | |
$15.37 | |
$4.46 | |
-- | |
-- |
CapsoVision, Inc. (CV) is trading at $6.77 in pre-market trading as of 2026-10-14 09:19:00, down 0.15% ($0.01) from the previous close of $6.78
Pre-market trading shows how investors are pricing CV before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, CapsoVision, Inc. (CV) moved from $6.59 to $6.77, representing a gain of 2.81% ($0.18).
The stock traded between $6.11 and $6.81 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 86.83 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 21.2%
CV is currently trading at $6.77, placing it 21.2% of the way from its 52-week low of $4.46 to its 52-week high of $15.37. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 99 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of CapsoVision, Inc. (CV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.